Digital AI is redefining decision-making in biopharma R&D AI has kickstarted a new wave of innovation in biopharma R&D.
Digital Digital tools must be used in pharma manufacturing to keep p... The pace of change in drug discovery and clinical development has been unmatched in recent years, with technologies such as AI accelerating these processes.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
